Literature DB >> 11497296

Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells.

M Abdul1, N Hoosein.   

Abstract

BACKGROUND: Anticonvulsants/antiepileptics inhibit high-frequency firing of action potentials that occur during an epileptic seizure, by mechanisms such as blocking sodium and calcium ion conductances. High sodium channel expression has been previously associated with aggressive behavior of prostate cancer (PCa) cell lines. The anticonvulsant phenytoin is known to inhibit the secretory activity and growth of human osteoblastic cells.
MATERIALS AND METHODS: The effect of four anticonvulsants on the secretion of prostate-specific antigen (PSA) and interleukin-6 (IL-6) by human PCa cell lines (LNCaP, DU-145 and PC-3) was studied using immunoanalysis.
RESULTS: Phenytoin and carbamazepine, which inactivate voltage-gated sodium channels, inhibited the secretion of PSA by LNCaP and IL-6 by DU-145 and PC-3 cell lines. Valproate and ethosuximide, which block calcium channels, had somewhat lower antisecretory effects. The growth of the three PCa cell lines in Matrigel was inhibited by all four anticonvulsants, at clinically-relevant doses.
CONCLUSION: Further study of the usefulness of anticonvulsants in PCa therapy is warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11497296

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  23 in total

1.  Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro.

Authors:  P U Onganer; M B A Djamgoz
Journal:  J Membr Biol       Date:  2005-03       Impact factor: 1.843

2.  The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells.

Authors:  Xia Zhao; Weihua Yang; Changwen Shi; Wanshan Ma; Jianing Liu; Yunshan Wang; Guosheng Jiang
Journal:  Tumour Biol       Date:  2010-11-27

3.  The effects of anesthetics on tumor progression.

Authors:  Lifang Mao; Suizhen Lin; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-03-08

4.  Fractal analysis and ionic dependence of endocytotic membrane activity of human breast cancer cells.

Authors:  Monika Krasowska; Zbigniew J Grzywna; Maria E Mycielska; Mustafa B A Djamgoz
Journal:  Eur Biophys J       Date:  2009-07-18       Impact factor: 1.733

5.  Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.

Authors:  Ken-Ichi Kitazoe; Masahiro Abe; Masahiro Hiasa; Asuka Oda; Hiroe Amou; Takeshi Harada; Ayako Nakano; Kyoko Takeuchi; Toshihiro Hashimoto; Shuji Ozaki; Toshio Matsumoto
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

6.  Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity.

Authors:  Yanning Ding; William J Brackenbury; Pinar U Onganer; Ximena Montano; Louise M Porter; Lucy F Bates; Mustafa B A Djamgoz
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

Review 7.  An emerging role for voltage-gated Na+ channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers.

Authors:  William J Brackenbury; Mustafa B A Djamgoz; Lori L Isom
Journal:  Neuroscientist       Date:  2008-10-20       Impact factor: 7.519

8.  Eicosapentaenoic acid inhibits voltage-gated sodium channels and invasiveness in prostate cancer cells.

Authors:  T Nakajima; N Kubota; T Tsutsumi; A Oguri; H Imuta; T Jo; H Oonuma; M Soma; K Meguro; H Takano; T Nagase; T Nagata
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

Review 9.  Dual roles of voltage-gated sodium channels in development and cancer.

Authors:  Faheemmuddeen Patel; William J Brackenbury
Journal:  Int J Dev Biol       Date:  2015       Impact factor: 2.203

Review 10.  Voltage-gated sodium channels and metastatic disease.

Authors:  William J Brackenbury
Journal:  Channels (Austin)       Date:  2012-09-01       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.